SYDNEY 28 MARCH 2008: Australian private equity firm Propel Investments today announced it has sold its 40% stake in MediHerb to Thompson Group Limited, a leading distributor of health supplements in Australia and New Zealand, for an undisclosed sum.

MediHerb is a major provider of herbal products to the Australian practitioner market with exports to countries such as the US, Canada, South Africa and New Zealand.

"The sale of MediHerb will realise more than 2.5 times our investment cost" said Peter Dowding, a Managing Director at Propel and former MediHerb board member.

"I would like to thank the staff at MediHerb and the management team, led by CEO Johan du Toit, for their significant contributions in making MediHerb a success," said Mr Dowding.

MediHerb CEO, Johan du Toit, said: "I believe the sale to Thompson's is a very positive outcome for all MediHerb stakeholders. The MediHerb management team also appreciate the close and supportive relationship with Propel as the company's major shareholder."

Separately, Propel announced that leading Australian and New Zealand funeral home operator Bledisloe, which is 73% owned by Propel, has successfully completed capital management initiatives supported by Bledisloe's debt financier, HBOS. As a result, Propel has received half of its original investment in the company.

For more information please visit www.propelinvestments.com.au or contact

P&L Corporate Communications

Ian Pemberton Ph:+61 (0)2 9241 6044 Mob+61 (0)402 256 576

David Lording Ph: +61 (0)2 9241 6044 Mob: +61 (0)419683 411